Table 2 Characteristics of sedation in sedated patients (n = 502)
From: Sedation at the end of life - a nation-wide study in palliative care units in Austria
Missing information (%) | |||
|---|---|---|---|
Median sedation time in hours (IQR) | 48 (10–72) | 12 (2 %) | |
n | % | 13 (3 %) | |
Type of sedation | 27 (5 %) | ||
Continuous | 356 | 71 % | |
Intermittent | 119 | 24 % | |
Indication for sedation | |||
Delirium | 254 | 51 % | 18 (4 %) |
Existential distress | 159 | 32 % | 18 (4 %) |
Dyspnea | 151 | 30 % | 17 (3 %) |
Pain | 99 | 20 % | 18 (4 %) |
Other individual reasons | 56 | 11 % | |
Not verifiable | 34 | 7 % | 17 (3 %) |
Drug used for sedation | |||
Midazolam | 395 | 79 % | 2 (<1 %) |
Diazepam | 14 | 3 % | 2 (<1 %) |
Propofol | 13 | 3 % | 2 (<1 %) |
Propthipendyl | 3 | 1 % | 2 (<1 %) |
Levomepromazin | 17 | 3 % | 2 (<1 %) |
Dihydrobenzperidol | 2 | <1 % | 2 (<1 %) |
Lorazepam | 66 | 13 % | 2 (<1 %) |
Clonazepam | - | - | 2 (<1 %) |
Haloperidol | 51 | 10 % | 2 (<1 %) |
Thiopental | - | - | 2 (<1 %) |
Type of administration | |||
i.v. bolus | 209 | 42 % | 36 (7 %) |
i.v. continuously | 253 | 50 % | 36 (7 %) |
s.c. bolus | 100 | 20 % | 36 (7 %) |
s.c. continuously | 56 | 11 % | 36 (7 %) |